Yahoo
Helsinki - Free Realtime Quote EUR

Nightingale Health Oyj (HEALTH.HE)

1.3650 -0.0400 (-2.85%)
As of 12:47:40 PM GMT+2. Market Open.
Chart Range Bar
Loading chart for HEALTH.HE
  • Previous Close 1.4050
  • Open 1.4100
  • Bid 1.3950 x --
  • Ask 1.4050 x --
  • Day's Range 1.3500 - 1.4300
  • 52 Week Range 0.7860 - 2.5950
  • Volume 17,307
  • Avg. Volume 90,910
  • Market Cap (intraday) 82.393M
  • Beta (5Y Monthly) 0.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.30

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is based in Helsinki, Finland.

nightingalehealth.com

101

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .

YTD Return

HEALTH.HE
31.71%
OMX Helsinki_PI (^OMXHPI)
0.00%

1-Year Return

HEALTH.HE
35.48%
OMX Helsinki_PI (^OMXHPI)
0.00%

3-Year Return

HEALTH.HE
29.63%
OMX Helsinki_PI (^OMXHPI)
0.00%

5-Year Return

HEALTH.HE
59.06%
OMX Helsinki_PI (^OMXHPI)
0.00%

Analyst Insights

View More

Analyst Price Targets

1.30 Low
1.30 Average
1.3650 Current
1.30

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -17.73%

  • Return on Equity (ttm)

    -32.15%

  • Revenue (ttm)

    5.5M

  • Net Income Avi to Common (ttm)

    -18.47M

  • Diluted EPS (ttm)

    -0.3100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.8M

  • Total Debt/Equity (mrq)

    8.40%

  • Levered Free Cash Flow (ttm)

    -6.04M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: